SBOT - Stellar Biotechnologies, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20189/30/20179/30/20169/30/2015
Total Revenue211.849228.2871,271.689758.689
Cost of Revenue445.32534.4531,127.828840.247
Gross Profit-233.471-306.166143.861-81.558
Operating Expenses
Research Development2,087.4021,735.41,494.445837.489
Selling General and Administrative2,757.3773,182.983,557.7723,419.545
Non Recurring----
Others----
Total Operating Expenses5,290.0995,452.8336,180.0455,097.281
Operating Income or Loss-5,078.25-5,224.546-4,908.356-4,338.592
Income from Continuing Operations
Total Other Income/Expenses Net40.101194.698-110.5241,532.363
Earnings Before Interest and Taxes-5,078.25-5,224.546-4,908.356-4,338.592
Interest Expense----
Income Before Tax-5,038.149-5,029.848-5,018.88-2,806.229
Income Tax Expense0.80.87.236.8
Minority Interest----
Net Income From Continuing Ops-5,038.949-5,030.648-5,026.08-2,843.029
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,038.949-5,030.648-5,026.08-2,843.029
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,038.949-5,030.648-5,026.08-2,843.029